SUM44PE - Cell Line (ID:51122)
HMS LINCS ID: | 51122 |
Name: | SUM44PE |
Alternative Names: | SUM-44PE |
LINCS ID: | |
Alternative ID: | |
Parent Cell Line: | |
Reference Source: | Asterand SUM-44PE |
Organism: | Homo sapiens |
Organ: | breast |
Tissue: | |
Cell Type: | |
Details of Cell Type: | |
Donor Sex: | |
Donor Age: | |
Donor Ethnicity: | |
Donor Health Status: | |
Disease: | DOID:3459, breast carcinoma |
Details of Disease: | luminal breast carcinoma |
Production Details: | From Asterand: derived from primary human luminal breast epithelial cells of a pleural effusion. |
Genetic Modification(s): | none |
Known Mutations: | |
Citation Information for Mutations: | |
Verification Reference Profile: | |
Growth Properties: | adherent |
Recommended Culture Conditions: | From Asterand: Ham’s F-12 + 1 g/L bovine serum albumin, 5 mM ethanolamine, 10 mM HEPES, 1 ug/mL hydrocortisone, 5 ug/mL insulin, 50 nM sodium selenite, 5 ug/mL apo-transferrin, 10 nM triiodo-L-thyronine |
Relevant Citations: | PMID 10604729 |
Usage Note: | |
Comments: | |
Date Publicly Available: | 2016-08-24 |
Most Recent Update: | 2016-08-24 |
Datasets:
HMS Dataset ID | Dataset Title | HMS Dataset Type |
---|---|---|
20268 | Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. | Analysis |
20269 | Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. | Analysis |
20370 | Breast Cancer Profiling Project – Proteomics 3: 1 total proteome dataset for a 27-cell line breast cancer panel under basal conditions | Proteomics |
Batch Information:
HMS LINCS Batch ID | Provider | Provider Catalog ID | Provider Batch ID |
---|---|---|---|
51122-1 | Stephen Ethier (Wayne State University and University of Michigan Medical School) |